Concepedia

Corina Oprea

CO

20

Publications

954

Citations

16

H-Index

2002

Active since

Affiliations

Sanofi (France)(Current)

Institut Gustave Roussy

Sanofi (United States)

Hospices Civils de Lyon

University of Milan

Corina Oprea is an author at Sanofi (France) specializing in oncology, medicine, and cancer research.

Top concepts

Publications per year

2002–2023

20

Publications

20

<i>Aspergillus</i>Galactomannan Detection in the Diagnosis of Invasive Aspergillosis in Cancer Patients

Raoul Herbrecht, Valérie Letscher‐Bru, Corina Oprea et al. · Journal of Clinical Oncology · 2002 · 391 citations

ACCELERATE and European Medicines Agency Paediatric Strategy Forum for medicinal product development of checkpoint inhibitors for use in combination therapy in paediatric patients

Andrew D.J. Pearson, Claudia Rössig, Giovanni Lesa et al. · European Journal of Cancer · 2020 · 66 citations · Full text

A Phase II Study of Coltuximab Ravtansine (SAR3419) Monotherapy in Patients With Relapsed or Refractory Acute Lymphoblastic Leukemia

Hagop M. Kantarjian, Bruno Lioure, Stella K. Kim et al. · Clinical Lymphoma Myeloma & Leukemia · 2015 · 64 citations · Full text

, , +10

A phase II multicenter study of the anti-CD19 antibody drug conjugate coltuximab ravtansine (SAR3419) in patients with relapsed or refractory diffuse large B-cell lymphoma previously treated with rituximab-based immunotherapy

Marek Trněný, Gregor Verhoef, Martin J.S. Dyer et al. · Haematologica · 2018 · 60 citations · Full text

A dose-finding Phase 2 study of single agent isatuximab (anti-CD38 mAb) in relapsed/refractory multiple myeloma

Joseph Mıkhael, Joshua Richter, Ravi Vij et al. · Leukemia · 2020 · 51 citations · Full text

Rows per page

1–5 of 20